Globus Medical ROA 2010-2022 | GMED
Current and historical return on assets (ROA) values for Globus Medical (GMED) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
| Globus Medical ROA - Return on Assets Historical Data |
| Date |
TTM Net Income |
Total Assets |
Return on Assets |
| 2022-09-30 |
$0.16B |
$1.98B |
7.90% |
| 2022-06-30 |
$0.16B |
$1.92B |
7.97% |
| 2022-03-31 |
$0.14B |
$2.00B |
7.38% |
| 2021-12-31 |
$0.15B |
$1.96B |
8.02% |
| 2021-09-30 |
$0.19B |
$1.91B |
10.45% |
| 2021-06-30 |
$0.18B |
$1.83B |
10.84% |
| 2021-03-31 |
$0.12B |
$1.74B |
7.53% |
| 2020-12-31 |
$0.10B |
$1.68B |
6.62% |
| 2020-09-30 |
$0.10B |
$1.54B |
6.31% |
| 2020-06-30 |
$0.09B |
$1.47B |
6.00% |
| 2020-03-31 |
$0.15B |
$1.48B |
10.11% |
| 2019-12-31 |
$0.16B |
$1.53B |
10.86% |
| 2019-09-30 |
$0.15B |
$1.45B |
10.66% |
| 2019-06-30 |
$0.14B |
$1.39B |
10.86% |
| 2019-03-31 |
$0.15B |
$1.34B |
11.83% |
| 2018-12-31 |
$0.16B |
$1.30B |
12.92% |
| 2018-09-30 |
$0.14B |
$1.24B |
12.41% |
| 2018-06-30 |
$0.14B |
$1.19B |
12.17% |
| 2018-03-31 |
$0.12B |
$1.13B |
11.23% |
| 2017-12-31 |
$0.11B |
$1.08B |
10.61% |
| 2017-09-30 |
$0.11B |
$1.04B |
11.02% |
| 2017-06-30 |
$0.11B |
$1.00B |
11.41% |
| 2017-03-31 |
$0.11B |
$0.96B |
11.48% |
| 2016-12-31 |
$0.10B |
$0.93B |
11.75% |
| 2016-09-30 |
$0.12B |
$0.90B |
13.70% |
| 2016-06-30 |
$0.12B |
$0.87B |
14.11% |
| 2016-03-31 |
$0.12B |
$0.84B |
14.32% |
| 2015-12-31 |
$0.11B |
$0.83B |
14.38% |
| 2015-09-30 |
$0.10B |
$0.80B |
13.67% |
| 2015-06-30 |
$0.10B |
$0.77B |
13.99% |
| 2015-03-31 |
$0.10B |
$0.74B |
14.31% |
| 2014-12-31 |
$0.09B |
$0.70B |
14.49% |
| 2014-09-30 |
$0.09B |
$0.65B |
14.16% |
| 2014-06-30 |
$0.08B |
$0.62B |
14.38% |
| 2014-03-31 |
$0.07B |
$0.60B |
12.61% |
| 2013-12-31 |
$0.07B |
$0.57B |
13.18% |
| 2013-09-30 |
$0.07B |
$0.53B |
13.99% |
| 2013-06-30 |
$0.06B |
$0.50B |
13.95% |
| 2013-03-31 |
$0.08B |
$0.47B |
17.84% |
| 2012-12-31 |
$0.07B |
$0.45B |
18.68% |
| 2012-09-30 |
$0.07B |
$0.42B |
18.27% |
| 2012-06-30 |
$0.07B |
$0.37B |
25.88% |
| 2012-03-31 |
$0.06B |
$0.36B |
36.26% |
| 2011-12-31 |
$0.06B |
$0.33B |
68.09% |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical Instruments Manufacturing |
$7.483B |
$0.958B |
|
Globus Medical, Inc. is a medical device company that develops and commercializes healthcare solutions for patients with musculoskeletal disorders. The company currently has its sales operations distributed across counties world wide. Its Musculoskeletal Solutions consist primarily of implantable devices, biologics, accessories, and unique surgical instruments, used in an expansive range of spinal, orthopedic and neurosurgical procedures. The spine products address the vast majority of conditions affecting the spine including degenerative conditions, deformity, tumors and trauma. Enabling Technologies are designed to enhance a surgeon's capabilities and streamline the complicated surgical procedures to be safer, less invasive, accurate and more reproducible to improve patient care and reduce radiation exposure for both patient and caregiver. The technology contains imaging, navigation and robotic assisted surgery solutions. It acquired all assets of StelKast, Inc. and Finnish engineering company Synoste Oy.
|
